Specifically, this study implicated that chemokine ligand (CCL)-2 and Interleukin 10 (IL10) of TAM markers are all strongly correlated with FN1 in STAD, as well as Interferon Regulatory Factor 5 (IRF5), Prostaglandin-Endoperoxide Synthase 2 (PTGS2) of M1 phenotype, and CD163, V-Set And Immunoglobulin Domain Containing 4 (VSIG4), Membrane Spanning 4-Domains A4A (MS4A4A) of M2 phenotype (p < 0.001; Figures 7B–D, Table 1). This evidence concerns the gene CCL2 and gastric adenocarcinoma.